EDIT
Editas Medicine Inc
Clinical-stage biotechnology company focused on CRISPR gene editing therapies
CUSIP: 28106W103HealthcareUS1 holder
Total Value
$12.22M
Total Shares
413.0K
Net Share Change
-99.2K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$12.22M413.0K shares
TRIM-99.2K(-19.4%)